期刊文献+

丙型肝炎病毒干扰素抵抗机制研究进展 被引量:3

Progress in Studies on Mechanism of Hepatitis C Virus Resistance to Interferon Treatment
下载PDF
导出
摘要 干扰素在宿主天然抗病毒防御及外源性治疗过程中具有显著作用。然干扰素作为丙型肝炎病毒(hepatitis C virus,HCV)感染的唯一治疗手段,干扰素抵抗广泛存在。HCV基因编码的病毒蛋白参与其中,使得肝细胞与病毒相互作用,影响干扰素信号传导及靶向抗病毒蛋白发挥作用。 Interferon plays a critical role in the host's natural defense against viral infections and in their treatment. Interferon is one of the two drugs that constitute the only antiviral therapy for hepatitis C virus(HCV) infection; however,in a certain proportion of cases the virus is resistant to interferon. Several HCV proteins have been shown to possess properties that enable the virus to evade the interferon-mediated cellular antiviral responses.
作者 任姗 陈新月
出处 《首都医科大学学报》 CAS 北大核心 2009年第6期799-804,共6页 Journal of Capital Medical University
基金 国家"十一五"科技重大专项(2008ZX10002-013)资助项目~~
  • 相关文献

参考文献26

  • 1Jose M C, Michael G, Manuela T P, et al. The role of positive selection in hepatitis C virus [ J ]. Infection, Genetics and Evolution, 2009,9 : 860-866.
  • 2Hideki W, Kazuyoshi N, Nobuyuki E, et al. Amino acid substitutions in PKR-eIF2 phosphorylation homology domain (PePHD) of hepatitis C virus E2 protein in genotype 2a/2b and 1b in Japan and interferon efficacy [J]. Hepatology Res, 2003,26:268-274.
  • 3Guillou-Guillemette L, Petsaris O, Payan C, et al. Identification of a duplication of the V3 domain in the NSSA region in HCV genotype lb infected patients:prevalence and relation with clinical outcome in two cohorts [ J ]. J Clin Virol, 2006,36 : 123.
  • 4Yue W, Naoya K, Amarsanaa J, et al. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response [ J ]. Gastroenterology, 2006,130 : 883-892.
  • 5Amab B, Keith M, Keith K L, et al. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes [ J ]. Virology, 2006,349:347-358.
  • 6Wenyu L, Won H C, Yoichi H, et al. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1 [J]. J Gastroenterol, 2005,128:1034- 1041.
  • 7Mona W, Nicola L M, Marco T, et al. Impaired interferon type I signalling in the liver modulates the hepatic acute phase response in hepatitis C virus transgenic mice [ J ]. J Hepatology, 2009,51:271-278.
  • 8Delhem N, Sabile A, Gajardo R, et al. HCV core, encoded by HCC tumor-derived sequences, binds PKR and in- creases its activity: a new model of PKR viral activator[ J ]. J Hepatol, 2001,34:25.
  • 9Sato Y, Nishida M, Suda R, et al. RAC-ROS-NF-KB-dependent up-regulation of angiotensin type 1 receptors in rat cardiac fibroblasts[ J ]. Molecular and Cellular Cardiology, 2007,42:29-30.
  • 10de Lucas Ramos, Rodriguez J M, S Lopez Martin. Contro- versias farmacologicas reflejadas en las guias y normativas nacionales e internacionales [ J ]. Archivos de Bronconeumologia, 2005,41 : 32-37.

二级参考文献3

  • 1Kurosaki M,Enomoto, N,Murakami T,et al . Analysis of genotypes and amino acid residues 2 209 to 2 248 of the NsSa region of hepatitis Cvirus in relation to the response to interferorr β therapy[J].Hepatol, 1997, 25:750-753.
  • 2Nakano I,Fukuda Y,Katano Y, et al, Why is the interferon sensitivity-detrnining region( ISDR) system useful in Japan? [J].J Hepatol,199,30:1014-1022.
  • 3Cale MI, Biakely CM, Kwieciszewski B, et al . Contol of PKR protienkinase by the nonstructural 5a protein: molecular mechanism of kinase regulation[J].Mol Cell Biol, 1998,18:5208-5218.

共引文献4

同被引文献33

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部